Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumors Lymphomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03028103
What this trial is testing

Open-Label, Multicenter, Two-Part, Phase 1 Study to Characterize Effects of a Moderate CYP3A Inhibitor on PK of Tazemetostat, Effects of Tazemetostat on PK of CYP2C8 and CYP2C19 Substrates, and Effect of Increased Gastric pH on PK of Tazemetostat in B-cell Lymphoma or Advanced Solid Tumor Patients

Who this might be right for
Diffuse Large B Cell LymphomaPrimary Mediastinal LymphomaMantle Cell Lymphoma+2 more
Epizyme, Inc. 32
Early research (Phase 1)Looking for participantsNCT05156203
What this trial is testing

Safety and Tolerability Study for T-1301 Capsules to Treat Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorLymphoma
Taivex Therapeutics Corporation 30
Testing effectiveness (Phase 2)Ended earlyNCT04775680
What this trial is testing

Study of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin Lymphoma

Who this might be right for
Solid TumorNon Hodgkin Lymphoma
Adagene (Suzhou) Limited 25
Early research (Phase 1)Ended earlyNCT00089089
What this trial is testing

Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas

Who this might be right for
Hematopoietic/Lymphoid CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 42
Early research (Phase 1)Study completedNCT01356173
What this trial is testing

Evaluating the Safety and Tolerability of GDC-0349 in Patients With Locally Advanced or Metastatic Solid Tumors or Non Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma, Solid Tumor
Genentech, Inc. 10
Early research (Phase 1)Ended earlyNCT04254107
What this trial is testing

A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

Who this might be right for
Non-small Cell Lung CancerGastric CarcinomaGastroesophageal Junction Carcinoma+9 more
Seagen Inc. 133
Early research (Phase 1)WithdrawnNCT02582827
What this trial is testing

QUILT-3.014: A Trial of ABI-011 Administered Weekly in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Neoplastic Disease
NantBioScience, Inc.
Early research (Phase 1)UnknownNCT05150405
What this trial is testing

A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors

Who this might be right for
Solid TumorLymphoma, Non-Hodgkin
Qilu Pharmaceutical Co., Ltd. 54
Testing effectiveness (Phase 2)Looking for participantsNCT04390737
What this trial is testing

Evaluate the Safety and Clinical Activity of HH2853

Who this might be right for
FL LymphomaEpithelioid SarcomaPeripheral T Cell Lymphoma+1 more
Haihe Biopharma Co., Ltd. 254
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439188
What this trial is testing

Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00520637
What this trial is testing

A Phase I, Study to Evaluate the Safety and Tolerability of Intravenous EZN-2208 in Patients With Advanced Solid Tumors or Lymphoma (EZN-2208-01)

Who this might be right for
Advanced Solid TumorsLymphoma
Enzon Pharmaceuticals, Inc. 34
Early research (Phase 1)UnknownNCT00003073
What this trial is testing

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Pacira Pharmaceuticals, Inc 15
Early research (Phase 1)Looking for participantsNCT05357651
What this trial is testing

Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma（Keyplus-001）

Who this might be right for
Solid TumorLymphoma
L & L Bio Co., Ltd., Ningbo, China 100
Early research (Phase 1)Study completedNCT00215605
What this trial is testing

Study of XL184 (Cabozantinib) in Adults With Advanced Malignancies

Who this might be right for
LymphomaCancerThyroid Carcinoma
Exelixis 85
Early research (Phase 1)Ended earlyNCT02376699
What this trial is testing

Safety Study of SEA-CD40 in Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Squamous CellHodgkin Disease+17 more
Seagen Inc. 159
Early research (Phase 1)Study completedNCT00741871
What this trial is testing

SB1518 for the Treatment of Advanced Lymphoid Malignancies

Who this might be right for
Lymphoma, MalignantHodgkin's LymphomaB Cell Lymphoma
S*BIO 35
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Early research (Phase 1)Study completedNCT00298779
What this trial is testing

Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.

Who this might be right for
TumorsNon-Hodgkins's Lymphoma
Millennium Pharmaceuticals, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT04439240
What this trial is testing

Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 52
Early research (Phase 1)Study completedNCT00768391
What this trial is testing

Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available

Who this might be right for
Solid Tumors
Eli Lilly and Company 20
Next Page